NO20060002L - Enhetssammensetning av FSH og hCG - Google Patents

Enhetssammensetning av FSH og hCG

Info

Publication number
NO20060002L
NO20060002L NO20060002A NO20060002A NO20060002L NO 20060002 L NO20060002 L NO 20060002L NO 20060002 A NO20060002 A NO 20060002A NO 20060002 A NO20060002 A NO 20060002A NO 20060002 L NO20060002 L NO 20060002L
Authority
NO
Norway
Prior art keywords
hcg
fsh
administration
unit composition
ovulation
Prior art date
Application number
NO20060002A
Other languages
English (en)
Norwegian (no)
Inventor
Marco Filicori
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33489458&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20060002(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of NO20060002L publication Critical patent/NO20060002L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Reproductive Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
NO20060002A 2003-06-03 2006-01-02 Enhetssammensetning av FSH og hCG NO20060002L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/452,926 US20040248784A1 (en) 2003-06-03 2003-06-03 Unitary combinations of FSH and hCG
PCT/IB2004/001813 WO2004105788A1 (en) 2003-06-03 2004-06-02 UNITARY COMBINATION OF FSH AND hCG

Publications (1)

Publication Number Publication Date
NO20060002L true NO20060002L (no) 2006-03-02

Family

ID=33489458

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20060002A NO20060002L (no) 2003-06-03 2006-01-02 Enhetssammensetning av FSH og hCG

Country Status (15)

Country Link
US (6) US20040248784A1 (pt)
EP (2) EP2292252B1 (pt)
JP (1) JP2006526609A (pt)
KR (2) KR20070118195A (pt)
CN (2) CN101156945A (pt)
AU (1) AU2004243256B2 (pt)
BR (1) BRPI0410968A (pt)
CA (1) CA2524755A1 (pt)
ES (2) ES2753822T3 (pt)
MX (1) MXPA05012967A (pt)
NO (1) NO20060002L (pt)
NZ (1) NZ543403A (pt)
RU (1) RU2332228C2 (pt)
WO (1) WO2004105788A1 (pt)
ZA (1) ZA200509814B (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040248784A1 (en) * 2003-06-03 2004-12-09 Marco Filicori Unitary combinations of FSH and hCG
US8260985B2 (en) * 2007-10-05 2012-09-04 Pano Logic, Inc. Universal serial bus assistance engine
TWI488640B (zh) 2008-04-16 2015-06-21 菲瑞茵國際中心股份有限公司 藥學製劑
CN102309745B (zh) * 2008-09-17 2013-05-08 上海天伟生物制药有限公司 一种卵泡刺激素冻干针剂
CN102309744B (zh) * 2008-09-17 2013-05-08 上海天伟生物制药有限公司 一种绒毛膜促性腺激素冻干针剂
TWI532495B (zh) * 2009-10-05 2016-05-11 菲瑞茵國際中心股份有限公司 藥學製劑
US9320778B2 (en) 2010-09-29 2016-04-26 Ferring B.V. Method for controlled ovarian stimulation with combined FSH and hCG
WO2012120535A2 (en) * 2011-02-03 2012-09-13 Sanzyme Limited A composition comprising highly purified chorionic gonadotropin, it's formulation and uses of the same
WO2012127501A2 (en) * 2011-03-11 2012-09-27 Sanzyme Limited Composition for improving endometrial thickness during ovarian stimulation
WO2012127500A2 (en) * 2011-03-11 2012-09-27 Sanzyme Limited Composition for spermatogenesis
CA3163525A1 (en) 2011-03-31 2012-10-04 Ferring Bv. Pharmaceutical preparation
AU2012286048A1 (en) * 2011-07-18 2014-02-20 Arts Biologics A/S Long acting luteinizing hormone (LH) compound
JO3092B1 (ar) * 2011-08-08 2017-03-15 Ferring Bv مركب لتحفيز مسيطر عليه للمبيض
US20150272622A1 (en) * 2011-12-22 2015-10-01 Previvo Genetics, Llc Recovery and processing of human embryos formed in vivo
GB201517523D0 (en) * 2015-10-05 2015-11-18 Ostara Biomedical Ltd Methods and compositions for managing reproduction
SI3973982T1 (sl) 2017-09-01 2024-10-30 Ferring B. V. Sestavek za nadzorovano stimulacijo jajčnikov
WO2019211153A1 (en) * 2018-04-30 2019-11-07 Ferring B.V. Composition for controlled ovarian stimulation
CN108969755A (zh) * 2018-07-17 2018-12-11 山东农业大学 一种控制驴排卵时间段相对集中的药物组合物及使用方法
CN110787286B (zh) * 2019-11-21 2024-06-25 重庆市畜牧科学院 Fsh和hcg在制备促进睾丸细胞功能恢复的药物中的应用
WO2025149590A1 (en) * 2024-01-09 2025-07-17 Ferring B.V. Compositions and methods for controlled ovarian stimulation

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4923805A (en) 1983-11-02 1990-05-08 Integrated Genetics, Inc. Fsh
US5635475A (en) * 1987-12-21 1997-06-03 Applied Research Systems Ars Holding N.V. Site-directed mutagenesis modified glycoprotein hormones and methods of use
IE64738B1 (en) 1990-03-20 1995-09-06 Akzo Nv Stabilized gonadotropin containing preparations
EP0695171B1 (en) * 1993-04-28 1996-12-18 Akzo Nobel N.V. Lyospheres comprising gonadotropin
TW518235B (en) * 1997-01-15 2003-01-21 Akzo Nobel Nv A gonadotropin-containing pharmaceutical composition with improved stability on prolong storage
CA2372714A1 (en) 1999-05-07 2000-11-16 Stephen Franks The use of luteinizing hormone in the induction of pauci-or unifolliculogenesis
DE60238490D1 (de) 2001-09-12 2011-01-13 Merck Serono Sa Verwendung von humanem choriongonadotropin (hcg) und luteinisierendem hormon (lh) zur regulierten hyperstimulation der eierstöcke
HRP20040087A2 (en) 2001-09-12 2004-12-31 Applied Research Systems USE OF hCG IN CONTROLLED OVARIAN HYPERSTIMULATION
SI1434600T1 (sl) * 2001-09-12 2009-06-30 Serono Lab Uporaba lh za kontrolirano hiperstimulacijo ovarijev
US6818613B2 (en) * 2001-11-07 2004-11-16 Ortho-Mcneil Pharmaceutical, Inc. Aqueous sustained-release formulations of proteins
EP1364658A1 (en) * 2002-05-24 2003-11-26 Applied Research Systems ARS Holding N.V. Use of varying ratios of gonadotrophins in controlled ovarian hyperstimulation
AU2003269904A1 (en) * 2002-07-10 2004-01-23 The Ohio State University Research Foundation Antigen-polymer compositions
JP2006522151A (ja) 2003-04-01 2006-09-28 アプライド リサーチ システムズ エーアールエス ホールディング ナームロゼ フェンノートシャップ 不妊症におけるホスホジエステラーゼ阻害剤
US20040248784A1 (en) * 2003-06-03 2004-12-09 Marco Filicori Unitary combinations of FSH and hCG

Also Published As

Publication number Publication date
ES2451028T3 (es) 2014-03-26
CN1826135A (zh) 2006-08-30
EP2292252A2 (en) 2011-03-09
RU2005136527A (ru) 2006-07-27
ZA200509814B (en) 2007-01-31
US20040248784A1 (en) 2004-12-09
US7964562B2 (en) 2011-06-21
NZ543403A (en) 2008-05-30
US20120015879A1 (en) 2012-01-19
MXPA05012967A (es) 2006-03-17
WO2004105788A1 (en) 2004-12-09
JP2006526609A (ja) 2006-11-24
CA2524755A1 (en) 2004-12-09
US20170281731A1 (en) 2017-10-05
US7985732B2 (en) 2011-07-26
US20060135421A1 (en) 2006-06-22
AU2004243256A1 (en) 2004-12-09
EP1633389A1 (en) 2006-03-15
RU2332228C2 (ru) 2008-08-27
EP2292252A3 (en) 2012-08-29
EP1633389B1 (en) 2013-12-11
ES2753822T3 (es) 2020-04-14
EP2292252B1 (en) 2019-08-07
US20080119394A1 (en) 2008-05-22
US20080108571A1 (en) 2008-05-08
CN101156945A (zh) 2008-04-09
KR20060005417A (ko) 2006-01-17
AU2004243256B2 (en) 2007-11-29
KR20070118195A (ko) 2007-12-13
BRPI0410968A (pt) 2006-07-04

Similar Documents

Publication Publication Date Title
MXPA05012967A (es) Combinacion unitaria de fsh y hcg.
UA87959C2 (ru) Применение экстрактов с vitex agnus castus, которые содержат фитоэстроген, который селективно модулирует бета-рецепторы эстрогена
MY120279A (en) Use of a celecoxib composition for fast pain relief
MXPA04004842A (es) Inhibidores de 11-(-hidroxiesteroide deshidrogenasa de tipo 1.
MXPA04004837A (es) Inhibidores de 11-??-hidroxiesteroide deshidrogenasa de tipo 1.
MXPA04004779A (es) Inhibidores de 11-beta-hidroxiesteroide deshidrogenasa de tipo 1.
NO20073831L (no) Medikamenter for behandling eller forebygging av fibrotiske sykdommer
IL203063A (en) Active blood cell counts with estrogen and their use in the treatment of women's sexual disorders
WO2004017913A3 (en) Arginine silicate inositol complex and use thereof
Silver et al. Integrating prehabilitation into the cancer survivorship framework
THOMPSON et al. Prolonged vasoconstriction due to ergotamine tartrate: report of a case with recovery, with objective evaluation of vascular findings
TW200626161A (en) Methods of hormonal treatment utilizing ascending-dose extended cycle regimens
Lu et al. Osteoporosis in old women, therapeutic selection
CN101417090A (zh) 健胃消滞丸的配方及其制备方法
CN104324018B (zh) 广藿香醇在制备男性性功能障碍药物或保健品中的应用
WO2004037233A3 (en) Use of glycogen phosphorylase inhibitors for treatment of cardiovascular diseases
CN101579124A (zh) 怀山药营养保健面粉
CA2472309A1 (en) Multiple dose aromatase inhibitor for treating infertility
NO20073942L (no) Farmasoytiske sammensetninger for behandling av sykdommer assosiert med NF-KB-aktivitet
CN102283925A (zh) 一种治疗带状疱疹引起的神经痛的中药
Tandowsky Prophylactic use of lanatoside C in auricular paroxysmal arrhythmias
TW200731977A (en) Use of estradiol valerate in combination with dienogest for the oral treatment of dysfunctional uterine bleeding in conjunction with oral contraception
CN204723231U (zh) 中医理疗牵引按摩床
CN101040994A (zh) 一种治疗脚气的配方
WO2003024394A3 (en) Method of treating benign prostatic hyperplasia and other beingn porstate conditions

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application